Summit Therapeutics plc

Director, Biostatistics

Summit Therapeutics plc$203K — $253K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in Statistics/Biostatistics with 8+ years or Masters (MS) with 11+ years in clinical trials
  • Proven experience in supporting oncology phase II/III clinical studies
  • Experience in managing regulatory submissions (NDA, sNDA, BLA)
  • Extensive knowledge of CDISC standards
  • Proficient in statistical software (SAS, R, EAST) for analysis and design
  • Strong communication skills (written and verbal)
  • Familiarity with ICH, FDA, and GCP guidelines

Responsibilities

  • Provide statistical support for oncology clinical studies
  • Contribute to protocol development and statistical methodologies
  • Develop statistical analysis and data presentation plans
  • Review and interpret clinical data, producing reports and publications
  • Assist in writing regulatory submission documents
  • Review vendor data specifications
  • Lead the adoption of novel statistical methodologies
  • Represent the biostatistics function in cross-functional teams
  • Develop department policies and quality plans
  • Manage relationships with CROs and vendors
  • Offer strategic statistical guidance to mitigate project risks
  • Engage with regulatory bodies during meetings

Benefits

  • Comprehensive health insurance
  • Flexible working hours
  • Professional development opportunities
  • Collaborative work environment
  • Paid time off and holidays
Full Job Description
Overview of Role:

Serves as the project level biostatistician and provides leadership within biostatistics function to develop and execute statistical strategy, study design, statistical analyses, and regulatory submissions for clinical trials in oncology. Partners with clinical science, regulatory and other team members in clinical development plans, authoring key clinical/regulatory/statistical documents, and ensuring exceptional delivery and interpretation of clinical data. Develops and implements biostatistics department policies, standards, procedures, and work-instructions in coordination with department leader and other functions. Represents biostatistics function in interactions with CROs, institutional review boards, and regulatory agencies.

Role and Responsibilities:
  • Provide technical leadership and statistical support to clinical development through the design and conduct of clinical studies in oncology
  • Support/contribute to protocol development to ensure appropriateness of trial design, sample size, and propose the use of meaningful and efficient statistical methodologies
  • Lead development of statistical analysis plans, data presentation plans, clinical development plans, biometrics related submission activities, and post-submission strategies/responses
  • Review the accuracy of clinical data, perform statistical analysis, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final reports, and publications
  • Write/review sections of meeting packages and assist in the development and review of other documents required for regulatory submissions and other regulatory processes
  • Review vendor data transfer specifications and ADaM programming specifications
  • Lead assessment and introduction of novel statistical methodologies to implement solutions
  • Represent biostatistics function or biometrics department in cross function teams
  • Work with department leader to develop and implement department policies, standards and procedures
  • Collaborate with clinical operations, data management and CRO to develop and implement CRFs, database design, and the overall data quality plan
  • Evaluate and manage CROs and other vendors, including scope-of-work, timelines, deliverables and budgets
  • Provide strategic statistical and regulatory guidance to anticipate challenges, mitigate risk, and ensure project success
  • Attend meetings with FDA or other health authorities to ensure ongoing agreement on project development
  • All other duties as assigned


Experience, Education and Specialized Knowledge and Skills:
  • PhD and a minimum of 8+ years of experience or Masters (MS) and a minimum of 11+ years of experience in statistics or biostatistics or related disciplines with clinical trials, pharmaceutical/biotech industry, or healthcare experience
  • Experience in supporting oncology phase II/III clinical studies
  • Experience in organizing and driving regulatory submissions (e.g. NDA, sNDA, BLA)
  • In-depth knowledge of CDISC standards
  • Technical expertise and knowledge of experimental design and analyses using SAS, R, or EAST, and etc.
  • Excellent written and verbal communication skills
  • Good working knowledge of ICH, FDA and GCP regulations and guidelines


This is the pay for this position

Pay Transparency

$203,000-$253,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit's Talent Acquisition team at [redacted] to obtain prior written authorization before referring any candidates to Summit.

About Summit Therapeutics plc

Summit Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to treat rare diseases with high unmet medical need. The company's lead product candidate, Ridinilazole, is a precision antibiotic that has the potential to treat Clostridium difficile infection (CDI) with a superior clinical profile compared to existing CDI treatments. Summit Therapeutics is also developing a pipeline of additional product candidates targeting genetic diseases and other indications.
Learn more about Summit Therapeutics plc
Size
105 employees
Market Cap
$842.6 million
Industry
Founded
2003
5 Year Trend
+9910%
Revenue
$1 million
NASDAQ

Similar Jobs

More Jobs at Summit Therapeutics plc

More Pharmaceuticals & Biotech Jobs

Find similar Director, Biostatistics jobs: